Skip to main content
logo
Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
10.08
-0.24 (-2.33%)
Oct 23, 2026, 4:00 PM EDT - Market closed

Fennec Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
353263174303252114
Market Cap Growth
45.64%51.48%-42.68%20.14%120.31%-40.49%
Enterprise Value
31226016531624795
Last Close Price
10.087.706.3211.229.604.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
16.7615.8837.3690.856.326.32
PS Ratio
5.975.893.6514.25164.24-
PB Ratio
8.327.41-29.57-26.06-98.137.26
P/TBV Ratio
8.337.41---7.26
P/OCF Ratio
--6.44---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.275.833.4814.88160.94-
EV/EBITDA Ratio
--45.94---
EV/EBIT Ratio
--64.41---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---3.29-2.66-9.690.32
Debt / EBITDA Ratio
--5.37---
Net Debt / Equity Ratio
-0.97-1.041.24-1.52-0.44-1.02
Net Debt / EBITDA Ratio
40.395.95-2.03---
Asset Turnover
0.980.771.320.790.06-
Inventory Turnover
1.622.871.980.92--
Quick Ratio
5.215.715.712.925.4912.76
Current Ratio
5.856.376.383.565.8013.54
Return on Equity (ROE)
-18.58%-65.82%---359.22%-77.36%
Return on Assets (ROA)
-1.17%-6.80%4.47%-29.67%-57.21%-39.99%
Return on Capital Employed (ROCE)
-1.80%-10.50%6.80%-66.10%-101.20%-83.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.01%-3.70%-0.25%-5.30%-9.41%-15.16%
Buyback Yield / Dilution
-16.68%-4.70%-2.71%-1.14%-1.03%-9.71%
SEC Filings: 10-K · 10-Q